13F HOLDINGS REPORT
FCPM III SERVICES B.V.
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001193125-25-281853
Total Value
$500.4M
Positions
13
Other Managers
3
Confidential Omitted
No
Holdings (13)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 4,648,025 | $132.2M | 26.42% |
| 2 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 4,564,359 | $129.8M | 25.94% |
| 3 | DYNE THERAPEUTICS INC | DYN | 4,036,476 | $51.1M | 10.20% |
| 4 | ENGENE HOLDINGS INC | ENGNW | 6,738,362 | $46.0M | 9.20% |
| 5 | ASTRIA THERAPEUTICS INC | 04635X102 | 4,107,537 | $29.9M | 5.98% |
| 6 | BICYCLE THERAPEUTICS PLC | BCYC | 3,452,330 | $26.7M | 5.34% |
| 7 | ENGENE HOLDINGS INC | ENGNW | 2,894,199 | $19.8M | 3.95% |
| 8 | VOR BIOPHARMA INC | VOR | 379,640 | $18.5M | 3.70% |
| 9 | DYNE THERAPEUTICS INC | DYN | 1,426,370 | $18.0M | 3.61% |
| 10 | REPLIMUNE GROUP INC | REPL | 4,158,368 | $17.4M | 3.48% |
| 11 | RAPT THERAPEUTICS INC | 75382E208 | 344,237 | $8.9M | 1.77% |
| 12 | ENGENE HOLDINGS INC | ENGNW | 2,403,072 | $1.7M | 0.35% |
| 13 | ENGENE HOLDINGS INC | ENGNW | 475,076 | $342,055 | 0.07% |